Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 24, 2007; 68 (17)

Share

This Week In Neurology

  • This week in NeurologyVolume 68, Number 17, April 24, 2007
    • Full Text
    • Full Text (PDF)

Editorials

  • Our commitment to rapid publicationBarriers and steps taken
    John H. Noseworthy
    • Full Text
    • Full Text (PDF)
  • Head-shaking nystagmus and new technology
    Timothy C. Hain
    • Full Text
    • Full Text (PDF)
  • Better late than never?The story of arterial recanalization in acute ischemic stroke
    Ken Uchino, David C. Anderson
    • Full Text
    • Full Text (PDF)

Articles

  • Head-shaking nystagmus in lateral medullary infarctionPatterns and possible mechanisms
    K. -D. Choi, S. -Y. Oh, S. -H. Park, J. -H. Kim, J. -W. Koo, J. S. Kim
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
    P. -P. Derost, L. Ouchchane, D. Morand, M. Ulla, P. -M. Llorca, M. Barget, B. Debilly, J. -J. Lemaire, F. Durif
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Quetiapine for agitation or psychosis in patients with dementia and parkinsonism
    Roger Kurlan, Jeffrey Cummings, Rema Raman, Leon Thal
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Recanalization after intravenous thrombolysisDoes a recanalization time window exist?
    M. T. Wunderlich, M. Goertler, T. Postert, E. Schmitt, G. Seidel, G. Gahn, C. Samii, E. Stolz
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora
    P. Gómez-Garre, E. Gutiérrez-Delicado, C. Gómez-Abad, J. Morales-Corraliza, V. E. Villanueva, S. Rodríguez de Córdoba, J. Larrauri, M. Gutiérrez, J. Berciano, J. M. Serratosa
    • Abstract
    • Full Text
    • Full Text (PDF)
  • New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p
    R. Nabbout, S. Baulac, I. Desguerre, N. Bahi-Buisson, C. Chiron, M. Ruberg, O. Dulac, E. LeGuern
    • Abstract
    • Full Text
    • Full Text (PDF)
  • FAME 3A novel form of progressive myoclonus and epilepsy
    J. A. Carr, P. E. van der Walt, J. Nakayama, Y. -H. Fu, V. Corfield, P. Brink, L. Ptacek
    • Abstract
    • Full Text
    • Full Text (PDF)
  • MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
    D. H. Miller, D. Soon, K. T. Fernando, D. G. MacManus, G. J. Barker, T. A. Yousry, E. Fisher, P. W. O'Connor, J. T. Phillips, C. H. Polman, L. Kappos, M. Hutchinson, E. Havrdova, F. D. Lublin, G. Giovannoni, A. Wajgt, R. Rudick, F. Lynn, M. A. Panzara, A. W. Sandrock
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Quantitative objective markers for upper and lower motor neuron dysfunction in ALS
    H. Mitsumoto, A. M. Uluğ, S. L. Pullman, C. L. Gooch, S. Chan, M. -X. Tang, X. Mao, A. P. Hays, A. G. Floyd, V. Battista, J. Montes, S. Hayes, S. Dashnaw, P. Kaufmann, P. H. Gordon, J. Hirsch, B. Levin, L. P. Rowland, D. C. Shungu
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Course of cerebral amyloid angiopathy–related inflammation
    C. Kinnecom, M. H. Lev, L. Wendell, E. E. Smith, J. Rosand, M. P. Frosch, S. M. Greenberg
    • Abstract
    • Full Text
    • Full Text (PDF)
  • How migraines impact cognitive functionFindings from the Baltimore ECA
    A. Kalaydjian, P. P. Zandi, K. L. Swartz, W. W. Eaton, C. Lyketsos
    • Abstract
    • Full Text
    • Full Text (PDF)

Special Article

  • AAN Board of Directors recommends formation of a companion association to establish a political action committee
    Bruce Sigsbee, Tom Swift, Rod Larson
    • Full Text
    • Full Text (PDF)

Clinical/Scientific Notes

  • PILOT TRIAL OF DILTIAZEM IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    B. H. Elsheikh, E. Bollman, M. Peruggia, W. King, G. Galloway, J. T. Kissel
    • Full Text
    • Full Text (PDF)
  • NARP MITOCHONDRIOPATHY: AN UNUSUAL CAUSE OF PROGRESSIVE MYOCLONIC EPILEPSY
    J. Jung, F. Mauguière, P. Clerc-Renaud, E. Ollagnon, B. Mousson de Camaret, P. Ryvlin
    • Full Text
    • Full Text (PDF)
  • DIAGNOSTIC VALUE OF ULTRASTRUCTURAL SKIN BIOPSY STUDIES IN CADASIL
    A. Malandrini, C. Gaudiano, S. Gambelli, G. Berti, G. Serni, S. Bianchi, A. Federico, M. T. Dotti
    • Full Text
    • Full Text (PDF)

Reflections: Neurology and the Humanities

  • The Button
    Michael J. Doherty
    • Full Text
    • Full Text (PDF)

NeuroImages

  • Impaired ipsilateral smooth pursuit and gaze-evoked nystagmus in paramedian pontine lesion
    B. -Y. Ahn, K. -D. Choi, J. Soo Kim, K. -P. Park, J. H. Bae, T. -H. Lee
    • Full Text
    • Full Text (PDF)
  • CT angiography and CT perfusion in post-CEA hyperperfusion syndrome
    Susanne Muehlschlegel, Barbara Voetsch, Aneesh B. Singhal
    • Full Text
    • Full Text (PDF)

Patient Page

  • How migraines affect cognitive function
    Steven C. Karceski
    • Full Text
    • Full Text (PDF)

Correspondence

  • QUANTIFICATION OF NEUROMETABOLITES IN SUBACUTE SCLEROSING PANENCEPHALITIS BY 1H-MRS
    Banu Anlar
    • Full Text
    • Full Text (PDF)
  • CSF TAU PROTEIN: A NEW PROGNOSTIC MARKER FOR GUILLAIN-BARRÉ SYNDROME
    Arthur Asbury
    • Full Text
    • Full Text (PDF)
  • CSF OPENING PRESSURE: REFERENCE INTERVAL AND THE EFFECT OF BODY MASS INDEX
    Francesco Bono, Aldo Quattrone
    • Full Text
    • Full Text (PDF)
  • VITAMINS AND ENTACAPONE IN LEVODOPA-INDUCED HYPERHOMOCYSTEINEMIA: A RANDOMIZED CONTROLLED STUDY
    Alessandro Di Rocco, Peter Werner
    • Full Text
    • Full Text (PDF)
  • TREATMENT OF CHILDHOOD MIGRAINE ATTACKS WITH ORAL ZOLMITRIPTAN AND IBUPROFEN
    Dina H. Kornblau
    • Full Text
    • Full Text (PDF)

DEPARTMENTS

  • Calendar
    • Full Text
    • Full Text (PDF)
Back to top
PreviousNext
Previous IssueNext Issue
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Subscribe to e-Alerts
RSS
Advertisement
Popular on
Neurology
  • Most Read
  • Most Cited
Loading
  • Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
  • Practice guideline update summary: Acute treatment of migraine in children and adolescentsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
  • Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
  • Quality improvement in neurologyMild cognitive impairment quality measurement set
  • Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
More...
Advertisement
Neurology: 93 (23)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2019 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise